Local News Athira Reels in $85M for Phase 2/3 Alzheimer’s Study Fierce Biotech | June 8, 2020 Athira Pharma changed its name last year to reflect its focus on regenerative medicine. Now,…emcguinnJune 8, 2020 Read More
Local News Infectious Disease Research Institute is Working on a Multiplier Effect for Coronavirus Vaccine GeekWire | June 5, 2020 Seattle’s Infectious Disease Research Institute is working with Houston’s Baylor College of Medicine to multiply the doses of a…emcguinnJune 5, 2020 Read More
Local News Large-Scale Survey of Seattle-Area Kids Shows 1% Had Antibodies to the Coronavirus The Seattle Times | June 5, 2020 About 1% of kids who visited a Seattle hospital in April had been infected with…emcguinnJune 5, 2020 Read More
Local News Researchers use Brain Imaging to Demonstrate Weaker Neural Suppression in Individuals with Autism UW | June 4, 2020 People with autism spectrum disorder, or ASD, may experience sensory hypersensitivity more often than people…emcguinnJune 4, 2020 Read More
Local News CSL Behring and Seattle Children’s Research Institute to Advance Gene Therapy Treatments for Primary Immunodeficiency Diseases BioSpace | June 3, 2020 Seattle Children's Research Institute, one of the top pediatric research institutions in the world, and…emcguinnJune 3, 2020 Read More
Local News In Cancer, the Context ‘Makes’ the Mutation Fred Hutch | June 2, 2020 In cancer, it’s tempting to divide genes into two camps: those that suppress cancer and…emcguinnJune 2, 2020 Read More
Local News CTI BioPharma Announces Enrolment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical Trial CTI BioPharma Corp. | June 2, 2020 CTI BioPharma Corp. today announced that it has enrolled the first patient in the Phase…emcguinnJune 2, 2020 Read More
Local News The Most Common Organism in the Oceans Harbors a Virus in its DNA UW | June 1, 2020 The most common organism in the oceans, and possibly on the entire planet, is a…emcguinnJune 1, 2020 Read More
Local News Seattle Genetics Announces Positive Results from Exploratory Analyses of HER2CLIMB for TUKYSA™ (tucatinib) in Brain Metastases Patients with HER2-Positive Breast Cancer Seattle Genetics | June 1, 2020 Seattle Genetics, Inc. today announced positive results from exploratory analyses of intracranial efficacy, including survival,…emcguinnJune 1, 2020 Read More
Local News Are Children Making Antibodies That Will Protect Against Future COVID-19 Infections? Seattle Children's | May 29, 2020 When Dr. Janet Englund (pictured), a member of the Center for Clinical Translational Research at Seattle Children’s Research Institute,…emcguinnMay 29, 2020 Read More